Background <p>Infantile hemangiomas are considered as the most common benign vascular tumors in pediatric patients. Ulceration is one of the most frequent complications that typically occur at 2–3&#xa0;months after birth.</p> Case presentation <p>A Caucasian Georgian male infant started to develop a hemangioma at 5&#xa0;days old. At 3&#xa0;weeks old, a pediatrician diagnosed it, and the patient was referred to a dermatologist. A week after starting initial treatment, at 4&#xa0;weeks of age, the hemangioma ulcerated. Despite changing the initial treatment, the ulceration worsened. At 6&#xa0;weeks old, topical timolol and mupirocin were initiated, leading to complete healing within 4&#xa0;weeks. Timolol is still being applied, and follow-up visits showed no further ulceration.</p> Conclusion <p>Although the exact cause of the unusual ulcer development is unknown, we advise physicians to avoid prescribing topical ointments that have not been proven effective and safe for treating hemangioma.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Atypical development and swift resolution of an ulcerated hemangioma: a case report

  • Konstantine Chakhunashvili,
  • Eka Kvirkvelia,
  • Davit G. Chakhunashvili

摘要

Background

Infantile hemangiomas are considered as the most common benign vascular tumors in pediatric patients. Ulceration is one of the most frequent complications that typically occur at 2–3 months after birth.

Case presentation

A Caucasian Georgian male infant started to develop a hemangioma at 5 days old. At 3 weeks old, a pediatrician diagnosed it, and the patient was referred to a dermatologist. A week after starting initial treatment, at 4 weeks of age, the hemangioma ulcerated. Despite changing the initial treatment, the ulceration worsened. At 6 weeks old, topical timolol and mupirocin were initiated, leading to complete healing within 4 weeks. Timolol is still being applied, and follow-up visits showed no further ulceration.

Conclusion

Although the exact cause of the unusual ulcer development is unknown, we advise physicians to avoid prescribing topical ointments that have not been proven effective and safe for treating hemangioma.